Audrey Francès

Audrey Francès

Auto-generated profile, based on publicly available information

Audrey Francès

Team Therapeutic Innovation in Pancreatic Cancer, Centre de Recherches en Cancérologie de Toulouse, CRCT, Université de Toulouse, Inserm, CNRS, Toulouse, France

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 January 2024 in Cancer Research
Verified
Journal Article
Open access
PDF file
ALAudrey Lumeau
Audrey Lumeau
NBNicolas BERY
Nicolas BERY
AFAudrey Francès
Audrey Francès
MGMarion Gayral
Marion Gayral
GLGuillaume Labrousse
Guillaume Labrousse
PCPierre Cordelier
Pierre Cordelier
Cytidine deaminase (CDA) functions in the pyrimidine salvage pathway for DNA and RNA syntheses and has been shown to protect cancer cells from deoxycytidine-based chemotherapies. In this study, we observed that CDA was overexpressed in pancreatic adenocarcinoma from patients at baseline and was essential for experimental tumor growth. Mechanistic investigations revealed that CDA localized to replication forks where it increased replication speed, improved replication fork restart efficiency, reduced endogenous replication stress, minimized DNA breaks, and regulated genetic stability during DNA replication. In cellular pancreatic cancer models, high CDA expression correlated with resistance to DNA-damaging agents. Silencing CDA in patient-derived primary cultures in vitro and in orthotopic xenografts in vivo increased replication stress and sensitized pancreatic adenocarcinoma cells to oxaliplatin. This study sheds light on the role of CDA in pancreatic adenocarcinoma, offering insights into how this tumor type modulates replication stress. These findings suggest that CDA expression could potentially predict therapeutic efficacy and that targeting CDA induces intolerable levels of replication stress in cancer cells, particularly when combined with DNA-targeted therapies. Significance: Cytidine deaminase reduces replication stress and regulates DNA replication to confer resistance to DNA-damaging drugs in pancreatic cancer, unveiling a molecular vulnerability that could enhance treatment response.

30 August 2024 in Communications Biology
Verified
Journal Article
Open access
PDF file
AFAudrey Frances
Audrey Frances
ALAudrey Lumeau
Audrey Lumeau
NBNicolas BERY
Nicolas BERY
MGMarion Gayral
Marion Gayral
LSLucille Stuani
Lucille Stuani
PCPierre Cordelier
Pierre Cordelier
Cytidine deaminase (CDA) converts cytidine and deoxycytidine into uridine and deoxyuridine as part of the pyrimidine salvage pathway. Elevated levels of CDA are found in pancreatic tumors and associated with chemoresistance. Recent evidence suggests that CDA has additional functions in cancer cell biology. In this work, we uncover a novel role of CDA in pancreatic cancer cell metabolism. CDA silencing impairs mitochondrial metabolite production, respiration, and ATP production in pancreatic cancer cells, leading to a so-called Pasteur effect metabolic shift towards glycolysis. Conversely, we find that CDA expression promotes mitochondrial biogenesis and oxidative phosphorylation, independently of CDA deaminase activity. Furthermore, we observe that patient primary cells overexpressing CDA are more sensitive to mitochondria-targeting drugs. Collectively, this work shows that CDA plays a non-canonical role in pancreatic cancer biology by promoting mitochondrial function, which could be translated into novel therapeutic vulnerabilities.

1 April 2024
Verified
Other
Open access
ALAudrey Lumeau
Audrey Lumeau
NBNicolas BERY
Nicolas BERY
AFAudrey Francès
Audrey Francès
MGMarion Gayral
Marion Gayral
GLGuillaume Labrousse
Guillaume Labrousse
PCPierre Cordelier
Pierre Cordelier
Supplementary Table from Cytidine Deaminase Resolves Replicative Stress and Protects Pancreatic Cancer from DNA-Targeting Drugs

1 April 2024
Verified
Other
Open access
ALAudrey Lumeau
Audrey Lumeau
NBNicolas BERY
Nicolas BERY
AFAudrey Francès
Audrey Francès
MGMarion Gayral
Marion Gayral
GLGuillaume Labrousse
Guillaume Labrousse
PCPierre Cordelier
Pierre Cordelier
Figure S4 from Cytidine Deaminase Resolves Replicative Stress and Protects Pancreatic Cancer from DNA-Targeting Drugs

1 April 2024
Verified
Other
Open access
ALAudrey Lumeau
Audrey Lumeau
NBNicolas BERY
Nicolas BERY
AFAudrey Francès
Audrey Francès
MGMarion Gayral
Marion Gayral
GLGuillaume Labrousse
Guillaume Labrousse
PCPierre Cordelier
Pierre Cordelier
Figure S3 from Cytidine Deaminase Resolves Replicative Stress and Protects Pancreatic Cancer from DNA-Targeting Drugs

1 April 2024
Verified
Other
Open access
ALAudrey Lumeau
Audrey Lumeau
NBNicolas BERY
Nicolas BERY
AFAudrey Francès
Audrey Francès
MGMarion Gayral
Marion Gayral
GLGuillaume Labrousse
Guillaume Labrousse
PCPierre Cordelier
Pierre Cordelier
Figure S6 from Cytidine Deaminase Resolves Replicative Stress and Protects Pancreatic Cancer from DNA-Targeting Drugs